Primary information |
---|
ID | antitb_1642, |
Name | 26213786 |
N-Terminal modification | Callyaerins 8 |
C-Terminal Modification | H-(Hyp)-LLPPVPLFG |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Hyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation |
Chirality | Cyclic |
Nature | 11 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Callyspongia aerizusa |
Inhibition Concentration | Mycobacterium Tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | IC90= 40 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1643, |
Name | 26213786 |
N-Terminal modification | Callyaerins 8 |
C-Terminal Modification | H-(Hyp)-LLPPVPLFG |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Hyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation |
Chirality | Cyclic |
Nature | 11 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Callyspongia aerizusa |
Inhibition Concentration | Mycobacterium Tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | MIC = 100 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1644, |
Name | 26213786 |
N-Terminal modification | Callyaerins 8 |
C-Terminal Modification | H-(Hyp)-LLPPVPLFG |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Hyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation |
Chirality | Cyclic |
Nature | 11 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Callyspongia aerizusa |
Cell Line | IC50= >100 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | THP-1 cell line |
In vivo Model | 50% reduction in bacterial load |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1645, |
Name | 26213786 |
N-Terminal modification | Callyaerins 8 |
C-Terminal Modification | H-(Hyp)-LLPPVPLFG |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Hyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation |
Chirality | Cyclic |
Nature | 11 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Callyspongia aerizusa |
Cell Line | IC90 = >100 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | THP-1 cell line |
In vivo Model | 90% reduction in bacterial load |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1646, |
Name | 26213786 |
N-Terminal modification | Callyaerins 8 |
C-Terminal Modification | H-(Hyp)-LLPPVPLFG |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Hyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation |
Chirality | Cyclic |
Nature | 11 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Callyspongia aerizusa |
Cell Line | IC50= >100 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | MRC-5 cell lines |
In vivo Model | 50% reduction in bacterial load |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1647, |
Name | 26213786 |
N-Terminal modification | Callyaerins 8 |
C-Terminal Modification | H-(Hyp)-LLPPVPLFG |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Hyp= Hydroxiproline, Residue 1-8 involved in cyclic bond formation |
Chirality | Cyclic |
Nature | 11 |
Source | D |
Origin | Cationic |
Species | Natural |
Strain | Derived from Callyspongia aerizusa |
Cell Line | IC90 = 100 μg/ml |
Inhibition Concentration | in vitro |
Sequence | 2015 |
Cytotoxicity | MRC-5 cell lines |
In vivo Model | 90% reduction in bacterial load |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |